Back to discover
Disease
Retinal Neovascularization
Late-stage therapeutic developmentEmerging research
1
Publications
8
Clinical trials
2008
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial with recent milestones.
Major developments
Major clinical milestoneWorth watching
Primary completion2025-09-22
Clinical MilestonesViewHide
Recently completed
Activity timeline1
- 2025-09-22ClinicalEfficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin in Diabetic Macular EdemaPrimary completion
Clinical trials
The current development programme across all trial phases.
Clinical programme
8
1
1
5
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- PloS one1
Leading researchers8
- D'Amore PA1
- Darland DC1
- Kurihara T1
- Maharaj AS1
- Saint-Geniez M1
- Sekiyama E1
- Tucker BA1
- Walshe TE1
Affiliations (unnormalised)1
- Schepens Eye Research Institute1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.